Lymphoseek (tilmanocept) 50 micrograms kit for radiopharmaceutical preparation: temporary extension of shelf life

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Lymphoseek
Active substance
tilmanocept
Therapeutic area (MeSH)
Radionuclide Imaging
Procedure number
EMEA/H/C/002085
Regulatory outcome
Maintenance
DHPC type
Medicine shortage
Human ATC code
V09IA09
Dissemination date
30/05/2022

How useful was this page?

Add your rating